(RZLV) Rezolve AI Ordinary Shares - Overview
Exchange: NASDAQ •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: GB00BQH8G337
Stock: AI Platform, Retail, E-Commerce, Consumer, Connections
Total Rating 8
Risk 25
Buy Signal -1.63
| Risk 5d forecast | |
|---|---|
| Volatility | 152% |
| Relative Tail Risk | -14.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.59 |
| Alpha | -27.09 |
| Character TTM | |
|---|---|
| Beta | 2.278 |
| Beta Downside | 2.048 |
| Drawdowns 3y | |
|---|---|
| Max DD | 91.85% |
| CAGR/Max DD | -0.40 |
Description: RZLV Rezolve AI Ordinary Shares January 17, 2026
Rezolve AI PLC (NASDAQ: RZLV) delivers generative-AI software that enables retailers, brands and manufacturers in the United Kingdom and United States to create personalized, omnichannel consumer experiences. The firm, founded in 2016 and headquartered in London, rebranded from Rezolve AI Limited to Rezolve AI PLC in March 2025. It is classified as a U.S.-listed common stock in the Application Software sub-industry.
According to the most recent quarterly filing (Q3 2025), Rezolve AI reported annualised recurring revenue (ARR) of roughly $12.5 million, reflecting a year-over-year growth rate of about 45 %. The company’s gross margin sits near 78 %, consistent with high-margin SaaS models. Industry-wide, the global AI-enabled retail software market is expanding at an estimated 20 % compound annual growth rate, while e-commerce gross merchandise volume in the U.S. and U.K. grew ≈ 12 % YoY in 2024, providing a tailwind for AI-driven personalization tools.
For a deeper quantitative assessment, you may find ValueRay’s peer-comparison dashboards useful for evaluating Rezolve AI’s relative valuation and growth outlook.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income: -195.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.48 > 0.02 and ΔFCF/TA -1.60 > 1.0 |
| NWC/Revenue: -559.5% < 20% (prev -26.4k%; Δ 25.8k% < -1%) |
| CFO/TA -0.48 > 3% & CFO -38.1m > Net Income -195.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (233.5m) vs 12m ago 12.13% < -2% |
| Gross Margin: 95.58% > 18% (prev 0.80%; Δ 9479 % > 0.5%) |
| Asset Turnover: 25.43% > 50% (prev 0.86%; Δ 24.57% > 0%) |
| Interest Coverage Ratio: -21.93 > 6 (EBITDA TTM -125.9m / Interest Expense TTM 5.88m) |
Altman Z'' -15.00
| A: -0.89 (Total Current Assets 22.6m - Total Current Liabilities 93.6m) / Total Assets 80.1m |
| B: -3.95 (Retained Earnings -316.1m / Total Assets 80.1m) |
| C: -2.58 (EBIT TTM -129.0m / Avg Total Assets 49.9m) |
| D: -3.35 (Book Value of Equity -316.4m / Total Liabilities 94.4m) |
| Altman-Z'' Score: -39.56 = D |
Beneish M 1.00
| DSRI: 1.00 (Receivables 1.59m/21.3k, Revenue 12.7m/169.7k) |
| GMI: 0.83 (GM 95.58% / 79.70%) |
| AQI: 2.02 (AQ_t 0.69 / AQ_t-1 0.34) |
| SGI: 74.83 (Revenue 12.7m / 169.7k) |
| TATA: -1.97 (NI -195.6m - CFO -38.1m) / TA 80.1m) |
| Beneish M-Score: 48.34 (Cap -4..+1) = D |
What is the price of RZLV shares?
As of February 01, 2026, the stock is trading at USD 2.58 with a total of 28,240,972 shares traded.
Over the past week, the price has changed by -17.83%, over one month by +0.00%, over three months by -36.92% and over the past year by +0.78%.
Over the past week, the price has changed by -17.83%, over one month by +0.00%, over three months by -36.92% and over the past year by +0.78%.
Is RZLV a buy, sell or hold?
Rezolve AI Ordinary Shares has received a consensus analysts rating of 4.40.
Therefore, it is recommended to buy RZLV.
- StrongBuy: 2
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RZLV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10 | 287.6% |
| Analysts Target Price | 10 | 287.6% |
| ValueRay Target Price | 2.3 | -10.1% |
RZLV Fundamental Data Overview January 26, 2026
P/S = 235.34
Revenue TTM = 12.7m USD
EBIT TTM = -129.0m USD
EBITDA TTM = -125.9m USD
Long Term Debt = 121.1k USD (from longTermDebt, two quarters ago)
Short Term Debt = 34.8m USD (from shortTermDebt, last quarter)
Debt = 35.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 25.7m USD (from netDebt column, last quarter)
Enterprise Value = 984.3m USD (958.6m + Debt 35.6m - CCE 9.86m)
Interest Coverage Ratio = -21.93 (Ebit TTM -129.0m / Interest Expense TTM 5.88m)
EV/FCF = -25.75x (Enterprise Value 984.3m / FCF TTM -38.2m)
FCF Yield = -3.88% (FCF TTM -38.2m / Enterprise Value 984.3m)
FCF Margin = -300.9% (FCF TTM -38.2m / Revenue TTM 12.7m)
Net Margin = -1540 % (Net Income TTM -195.6m / Revenue TTM 12.7m)
Gross Margin = 95.58% ((Revenue TTM 12.7m - Cost of Revenue TTM 561.0k) / Revenue TTM)
Gross Margin QoQ = 95.63% (prev 95.63%)
Tobins Q-Ratio = 12.29 (Enterprise Value 984.3m / Total Assets 80.1m)
Interest Expense / Debt = 5.93% (Interest Expense 2.11m / Debt 35.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -101.9m (EBIT -129.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.24 (Total Current Assets 22.6m / Total Current Liabilities 93.6m)
Debt / Equity = -2.49 (negative equity) (Debt 35.6m / totalStockholderEquity, last quarter -14.3m)
Debt / EBITDA = -0.20 (negative EBITDA) (Net Debt 25.7m / EBITDA -125.9m)
Debt / FCF = -0.67 (negative FCF - burning cash) (Net Debt 25.7m / FCF TTM -38.2m)
Total Stockholder Equity = -20.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -391.6% (out of range, set to none)
RoE = 967.6% (negative equity) (Net Income TTM -195.6m / Total Stockholder Equity -20.2m)
RoCE = 642.1% (negative capital employed) (EBIT -129.0m / Capital Employed (Equity -20.2m + L.T.Debt 121.1k))
RoIC = -1280 % (out of range, set to none) (NOPAT -101.9m / Invested Capital 7.97m)
WACC = 13.97% (E(958.6m)/V(994.2m) * Re(14.31%) + D(35.6m)/V(994.2m) * Rd(5.93%) * (1-Tc(0.21)))
Discount Rate = 14.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 437.8%
Fair Price DCF = unknown (Cash Flow -38.2m)
EPS Correlation: -41.19 | EPS CAGR: -0.82% | SUE: 0.0 | # QB: 0
Revenue Correlation: -6.44 | Revenue CAGR: 4.82% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=-0.06 | Chg30d=+0.015 | Revisions Net=+2 | Growth EPS=+75.3% | Growth Revenue=+143.5%
Revenue TTM = 12.7m USD
EBIT TTM = -129.0m USD
EBITDA TTM = -125.9m USD
Long Term Debt = 121.1k USD (from longTermDebt, two quarters ago)
Short Term Debt = 34.8m USD (from shortTermDebt, last quarter)
Debt = 35.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 25.7m USD (from netDebt column, last quarter)
Enterprise Value = 984.3m USD (958.6m + Debt 35.6m - CCE 9.86m)
Interest Coverage Ratio = -21.93 (Ebit TTM -129.0m / Interest Expense TTM 5.88m)
EV/FCF = -25.75x (Enterprise Value 984.3m / FCF TTM -38.2m)
FCF Yield = -3.88% (FCF TTM -38.2m / Enterprise Value 984.3m)
FCF Margin = -300.9% (FCF TTM -38.2m / Revenue TTM 12.7m)
Net Margin = -1540 % (Net Income TTM -195.6m / Revenue TTM 12.7m)
Gross Margin = 95.58% ((Revenue TTM 12.7m - Cost of Revenue TTM 561.0k) / Revenue TTM)
Gross Margin QoQ = 95.63% (prev 95.63%)
Tobins Q-Ratio = 12.29 (Enterprise Value 984.3m / Total Assets 80.1m)
Interest Expense / Debt = 5.93% (Interest Expense 2.11m / Debt 35.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -101.9m (EBIT -129.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.24 (Total Current Assets 22.6m / Total Current Liabilities 93.6m)
Debt / Equity = -2.49 (negative equity) (Debt 35.6m / totalStockholderEquity, last quarter -14.3m)
Debt / EBITDA = -0.20 (negative EBITDA) (Net Debt 25.7m / EBITDA -125.9m)
Debt / FCF = -0.67 (negative FCF - burning cash) (Net Debt 25.7m / FCF TTM -38.2m)
Total Stockholder Equity = -20.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -391.6% (out of range, set to none)
RoE = 967.6% (negative equity) (Net Income TTM -195.6m / Total Stockholder Equity -20.2m)
RoCE = 642.1% (negative capital employed) (EBIT -129.0m / Capital Employed (Equity -20.2m + L.T.Debt 121.1k))
RoIC = -1280 % (out of range, set to none) (NOPAT -101.9m / Invested Capital 7.97m)
WACC = 13.97% (E(958.6m)/V(994.2m) * Re(14.31%) + D(35.6m)/V(994.2m) * Rd(5.93%) * (1-Tc(0.21)))
Discount Rate = 14.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 437.8%
Fair Price DCF = unknown (Cash Flow -38.2m)
EPS Correlation: -41.19 | EPS CAGR: -0.82% | SUE: 0.0 | # QB: 0
Revenue Correlation: -6.44 | Revenue CAGR: 4.82% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=-0.06 | Chg30d=+0.015 | Revisions Net=+2 | Growth EPS=+75.3% | Growth Revenue=+143.5%